首页> Cancer research communications> Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nicholas J,Hornstein

第一单位： Medical Oncology Fellowship, University of Texas MD Anderson Cancer Center, Houston, Texas.

作者： Nicholas J,Hornstein ^[1] ; Mohammad A,Zeineddine ^[2] ; Betul B,Gunes ^[3] ; Andrew J,Pellatt ^[1] ; Mark,Knafl ^[4] ; Haifeng,Zhu ^[4] ; Anneleis F,Willett ^[2] ; Abdelrahman,Yousef ^[2] ; Suyu,Liu ^[4] ; Ryan,Sun ^[4] ; Andrew,Futreal ^[5] ; Scott E,Woodman ^[4] ; Melissa W,Taggart ^[6] ; Michael J,Overman ^[2] ; Daniel M,Halperin ^[2] ; Kanwal P,Raghav ^[2] ; John Paul,Shen ^[2]

作者单位： Medical Oncology Fellowship, University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.;Faculty of Medicine, Biruni University, Zeytinburnu, Istanbul, Turkey. ^[3] Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. ^[4] Genomic Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas. ^[5] Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. ^[6]

医学主题词人类(Humans);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);腺癌(Adenocarcinoma);老年人(Aged);阑尾肿瘤(Appendiceal Neoplasms);前瞻性研究(Prospective Studies);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);成年人(Adult);老年人, 80以上(Aged, 80 and over)

DOI 10.1158/2767-9764.CRC-24-0019

PMID 38709066

发布时间 2025-01-10

基金项目

K22 CA234406/CA/NCI NIH HHS/United States P30 CA016672/CA/NCI NIH HHS/United States CA234406/HHS | NIH | National Cancer Institute (NCI) RR180035/Cancer Prevention and Research Institute of Texas (CPRIT) RP240392/Cancer Prevention and Research Institute of Texas (CPRIT) CDA-7604125121/American Society of Clinical Oncology (ASCO) CA016672/HHS | NIH | National Cancer Institute (NCI)

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cancer research communications

2024年4卷5期

1363-1368页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Cancer research communications

2024年4卷5期

1363-1368页

检索历史清除

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

检索历史清除